247 filings
Page 8 of 13
424B3
pub6a9o 5tg7h7
15 Nov 22
Prospectus supplement
4:30pm
424B3
1pa18u
7 Nov 22
Prospectus supplement
6:26pm
DEFA14A
w037 hrpy41n7ut7
7 Nov 22
Additional proxy soliciting materials
6:21pm
8-K
eh8apm9c
7 Nov 22
Allarity Therapeutics Announces Adjournment of 2022 Annual Meeting of Stockholders
6:21pm
8-K
21dlft
14 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
ohe0q4lwzit6g00x0qpe
11 Oct 22
Provides Recent Operational Highlights, and Regains Compliance with NASDAQ Listing Requirements
4:15pm
424B3
ouda9l6ui4
7 Oct 22
Prospectus supplement
5:18pm
424B3
cdupnet xmkb
30 Sep 22
Prospectus supplement
4:52pm
8-K
ajvgwakadl1p94ub4fbd
30 Sep 22
Entry into a Material Definitive Agreement
4:49pm
DEFA14A
ifyns517r8i 0mbe
26 Sep 22
Additional proxy soliciting materials
4:36pm
424B3
77k32l0c
26 Sep 22
Prospectus supplement
4:34pm
8-K
qv7nnlbqqh9eq01e6ty2
26 Sep 22
Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors
4:30pm
DEFA14A
fub5md o0vc03u6h
19 Sep 22
Additional proxy soliciting materials
5:00pm
DEF 14A
k6lf4
19 Sep 22
Definitive proxy
4:34pm
8-K
0qrzf478bk6jzr ne
12 Sep 22
Allarity Therapeutics Announces Appointment of New Auditor
4:10pm
PRE 14A
oe7jliiz5uas u4
8 Sep 22
Preliminary proxy
5:00pm
6-K
qxitnxa24m 9uip69ajg
31 Aug 22
Report of Foreign Private Issuer
11:56am
8-K
zoo50 6mx
29 Aug 22
Regulation FD Disclosure
6:30am